ABOS

$0.22-7.72%visit website

Acumen Pharmaceuticals, Inc.

Market Cap

$16M

Live price × SEC shares (Oct 21, 2026)

Sector

Health Care

Industry

Biotechnology

Beta (raw)

0.50

60mo monthly vs SPY

P/E (TTM)

N/M

TTM to Sep 2026 · negative earnings

P/S (TTM)

—

Mkt cap / TTM revenue

P/B

0.5

Mkt cap / shareholders' equity

EV/EBITDA (TTM)

N/M

TTM to Sep 2026 · negative EBITDA

Loading…

Financial Statements

USD thousands	Q4 FY2025 Dec 31, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	Q3 FY2026 Sep 30, 2026	TTM Sep 30, 2026
Research & development	20,526	16,484	27,809	21,113	85,932
Total operating expenses	25,199	21,149	32,556	25,813	104,717
Operating income	(25,199)	(21,149)	(32,556)	(25,813)	(104,717)
Interest expense	1,087	1,069	1,094	999	4,249
Net income	(25,138)	(20,737)	(32,718)	(25,369)	(103,962)
EPS (basic) ($)		(0.33)	(0.45)	(0.35)	(1.55)
EPS (diluted) ($)		(0.33)	(0.45)	(0.35)	(1.55)
Weighted avg. shares (basic)		63,219	72,251	72,321
Weighted avg. shares (diluted)		63,219	72,251	72,321

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Oct 26, 2026, period ended Sep 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 22 more quarters, back to Jun 2020, with Tormere Pro.

Corporate Events (8-K)

2 filings in 12 months · 0 with priority itemsFull history →

Filed	Items	Filing
Oct 30, 2026 accepted 7:06 AM ET	7.01Reg FD disclosure8.01Other events	Document SEC ↗
Oct 26, 2026 accepted 7:09 AM ET	2.02Earnings release7.01Reg FD disclosure	Document SEC ↗

Signals

purchases / sales, 90d

Short Volume

42%

W/W -11.2pp

Market & Alt Data

News

Factor Profile

Pro

Pro feature

Fama-French factor analysis is available on the Pro plan.

Upgrade to Pro

Sort by

Type

Trade Date	Filed	Owner	Role	Type	Shares	Price	Value	Owned After
2026-06-17	2026-06-17	Porter Derrell	Director	Sale	13.0K	$2.33	$30K	35.5K	View
2026-06-16	2026-06-17	Porter Derrell	Director	Sale	12.8K	$2.33	$30K	35.5K	View
2026-06-15	2026-06-17	Porter Derrell	Director	Sale	6,460	$2.35	$15K	48.3K	View
2026-06-09	2026-06-10	Fountain Nathan B	Director	Sale	6,400	$2.23	$14K	48.1K	View
2026-03-06	2026-03-10	Meisner Derek M	Chief Legal Officer & Corp Sec	Sale	2,090	$3.26	$7K	174.0K	View

1–5 of 6

1 / 2

Recent News

Acumen Pharmaceuticals: 3 Key Takeaways for Long-Term Investors

Yahoo Finance · 2026-11-05

Which Penny Stock Looks Riskiest: Acumen Pharmaceuticals (NASDAQ:ABOS), Senti Biosciences (NASDAQ:SNTI), Theriva Biologics (NYSEAMERICAN:TOVX), Context Therapeutics (NASDAQ:CNTX) or Hain Celestial (NASDAQ:HAIN)?

kalkine.ca · 2026-11-04

US Unusual Volume Stocks: ONEG, CENN, SLGB and INLF in Latest Scan

ChartMill · 2026-11-02

Small-Cap Market Movers: Top Gainers and Losers on Nov. 2, 2026

ChartMill · 2026-11-02

12 Health Care Stocks Moving In Monday's After-Market Session

Benzinga · 2026-11-02

12 Health Care Stocks Moving In Monday's Intraday Session

Benzinga · 2026-11-02

Regeneron Pharmaceuticals To Rally Around 11%? Here Are 10 Top Analyst Forecasts For Monday

Benzinga · 2026-11-02

Acumen Pharmaceuticals(ABOS) Stock Options Chain | Quotes & News

Moomoo · 2026-11-02

BTIG Maintains Buy on Acumen Pharmaceuticals, Lowers Price Target to $1

Benzinga · 2026-11-02

Acumen Pharmaceuticals, Inc. (ABOS) Stock Price, News, Quote & History

Yahoo! Finance Canada · 2026-10-31

Acumen Pharmaceuticals Stock: ALTITUDE-AD Failure Destroys The Investment Thesis (ABOS)

Seeking Alpha · 2026-10-31

Acumen Pharmaceuticals: Altitude-AD Failure Destroys The Investment Thesis (Rating Downgrade)

SeekingAlpha · 2026-10-31

Postmarket Movers: After-Hours Gainers and Losers

ChartMill · 2026-10-30

Most Active Stocks on Oct. 30, 2026: Intel, ChowChow Cloud and Acumen in Focus

ChartMill · 2026-10-30

Acumen Pharmaceuticals, Inc. (ABOS) stock price, news, quote and history

Yahoo Finance Australia · 2026-10-30

Informational purposes only, not investment advice.

Date	Insider	Type	Shares	Value
2026-06-17	Porter Derrell	S	13,040	$30,318
2026-06-16	Porter Derrell	S	12,800	$29,772.8
2026-06-15	Porter Derrell	S	6,460	$15,148.7
2026-06-09	Fountain Nathan B	S	6,400	$14,272.64
2026-03-06	Meisner Derek M	S	2,090	$6,813.4

ABOS

Financial Statements

Corporate Events (8-K)

Signals

Factor Profile

Recent News

Acumen Pharmaceuticals, Inc. (ABOS)

Reporting Insiders

Factor Profile

Corporate Events (8-K)